402 related articles for article (PubMed ID: 22664975)
21. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
[TBL] [Abstract][Full Text] [Related]
22. Allosteric inhibition of HIV-1 integrase activity.
Engelman A; Kessl JJ; Kvaratskhelia M
Curr Opin Chem Biol; 2013 Jun; 17(3):339-45. PubMed ID: 23647983
[TBL] [Abstract][Full Text] [Related]
23. Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.
Gupta K; Brady T; Dyer BM; Malani N; Hwang Y; Male F; Nolte RT; Wang L; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
J Biol Chem; 2014 Jul; 289(30):20477-88. PubMed ID: 24904063
[TBL] [Abstract][Full Text] [Related]
24. Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication.
Desimmie BA; Humbert M; Lescrinier E; Hendrix J; Vets S; Gijsbers R; Ruprecht RM; Dietrich U; Debyser Z; Christ F
Mol Ther; 2012 Nov; 20(11):2064-75. PubMed ID: 22828501
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
26. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
[TBL] [Abstract][Full Text] [Related]
27. Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.
Singh PK; Li W; Bedwell GJ; Fadel HJ; Poeschla EM; Engelman AN
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146690
[TBL] [Abstract][Full Text] [Related]
28. Impact of LEDGIN treatment during virus production on residual HIV-1 transcription.
Vansant G; Vranckx LS; Zurnic I; Van Looveren D; Van de Velde P; Nobles C; Gijsbers R; Christ F; Debyser Z
Retrovirology; 2019 Apr; 16(1):8. PubMed ID: 30940165
[TBL] [Abstract][Full Text] [Related]
29. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
[TBL] [Abstract][Full Text] [Related]
30. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
Nakamura T; Nakamura T; Amano M; Miyakawa T; Yamagata Y; Matsuoka M; Nakata H
J Virol; 2020 Sep; 94(19):. PubMed ID: 32611758
[TBL] [Abstract][Full Text] [Related]
31. The future of integrase inhibitors of HIV-1.
Malet I; Calvez V; Marcelin AG
Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a Novel HIV-1 Integrase/p75 Interacting Inhibitor by Docking Screening, Biochemical Assay, and in Vitro Studies.
Wang Y; Lin HQ; Wang P; Hu JS; Ip TM; Yang LM; Zheng YT; Chi-Cheong Wan D
J Chem Inf Model; 2017 Sep; 57(9):2336-2343. PubMed ID: 28837332
[TBL] [Abstract][Full Text] [Related]
33. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B
PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705
[TBL] [Abstract][Full Text] [Related]
34. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
[TBL] [Abstract][Full Text] [Related]
36. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor.
Wang H; Jurado KA; Wu X; Shun MC; Li X; Ferris AL; Smith SJ; Patel PA; Fuchs JR; Cherepanov P; Kvaratskhelia M; Hughes SH; Engelman A
Nucleic Acids Res; 2012 Dec; 40(22):11518-30. PubMed ID: 23042676
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy.
De Luca L; Ferro S; Morreale F; Chimirri A
Mini Rev Med Chem; 2011 Jul; 11(8):714-27. PubMed ID: 21651465
[TBL] [Abstract][Full Text] [Related]
38. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells.
Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T
PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.
Hayouka Z; Rosenbluh J; Levin A; Loya S; Lebendiker M; Veprintsev D; Kotler M; Hizi A; Loyter A; Friedler A
Proc Natl Acad Sci U S A; 2007 May; 104(20):8316-21. PubMed ID: 17488811
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
